Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes

Immunotherapy has achieved success in the treatment of esophageal squamous cell carcinoma (ESCC). However, studies concerning immune phenotypes within the ESCC microenvironment and their relationship with prognostic outcomes are limited. We constructed and validated an individual immune-related risk...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Cell Dev Biol
Auteurs principaux: Zhang, Chaoqi, Luo, Yuejun, Zhang, Zhen, Zhang, Zhihui, Zhang, Guochao, Wang, Feng, Che, Yun, Fang, Lingling, Zhang, Yi, Sun, Nan, He, Jie
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Cell and Developmental Biology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7773787/
https://ncbi.nlm.nih.gov/pubmed/33392181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.580005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires